ENTITY
Yunnan Baiyao Group Co.,

Yunnan Baiyao Group Co., (000538 CH)

62
Analysis
Health Care • China
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
bullish•Cross Asset Strategy
•19 Mar 2019 08:41

The China A-Share Revolution

Copley Fund Research analyse the holdings of long-only Global Emerging Market equity funds. All of the Funds in this analysis are actively managed...

Logo
1.1k Views
Share
•09 Oct 2017 16:15

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

•21 May 2017 18:37

Top Chinese Pharma Companies Seeking Deals in the US

The top 20 Chinese pharmaceutical companies are seeking US acquisitions, taking advantage of a lull in healthcare M&A because of regulatory...

Logo
521 Views
Share
•09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

•30 Jan 2017 13:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

x